“Estimating the Cost-Effectiveness of Treatment for Prevention of Thromboembolic Events in at-Risk Adults With Non-Valvular Atrial Fibrillation”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 19, no. 1, Feb. 2018, https://doi.org/10.7175/fe.v19i1.1346.